Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
You've explained it in a much clearer way Wild and sums it up perfectly!
NDN sorry but you're talking absolute nonsense.
It will help the vast majority of spread bettors (buyers!), as they can buy more Avacta stock without needing to have additional funds in their account.
Example being
I want £100 a point on Avacta which = 10,000 shares. I will only have to put down a deposit of 20% instead of the current 25%. So I could add further avacta news using the same amount of funds in my account.
Current holders will see their IG equity % lower by 5% so they can if they wanted to buy more.
And another 100k x 2 buys at 12:05 and 12:07 at a premium.
Something cooking?
Worth reading this thread with the images, very well explained why our test would detect it and also worth remembering that Al has previously said that because of the region we bind to there shouldnt be any problems (if needed they can just develop a new affimer and slot it in within a few weeks)
https://twitter.com/Ophidian18/status/146473641159315046
Visainn - this list is for pro use tests only, so doesnt effect HUA at all. The document clearly stats the following:
? The EU common list of antigen tests does not include rapid antigen self-tests. It only includes those rapid antigen tests that are conducted by trained healthcare personnel or trained operators where appropriate (in line with Commission Recommendation (EU) 20202/1743 of 18 November 2020).
On 6 July 2021 the Technical Working Group agreed that that the common list should not include rapid antigen self-tests
Thats the one vrmnd. Looks like their track record is on par if not worse than Jupiter.
"In Australian dollar terms, Bronte’s Australian “Amalthea” fund returned negative 24.3 per cent for the 12 months to March 31, 2021. Over the same period, Bronte’s benchmark, the MSCI World Index (in AUD), returned 23.9 per cent. Bronte therefore underperformed its benchmark by 48.2 per cent.
In US dollars, Bronte’s Cayman “Callisto” fund returned negative 7.5 per cent over the 12 months to March 31. The MSCI World Index (in USD) returned 54.6 per cent in the same period, so Bronte’s underperformance was 62.1 per cent."
Bronte Capital have a 0.5% short on AVCT. Also taken one out on DDDD. Both stocks are at lows with both due multiple catalysts in Q4.
Very clear this is an algorithm short rather than knowing anything, and it helps explain the price action of late.
Going to be very fun watching 2 companies who are short fight it out to close when the big news does land. Remember its very hard to buy any stock when Avacta gets momentum, so will be one massive squeeze for Jupiter and Bronte both trying to buy back shares in order to close out their short.
Time to watch them burn (hopefully very soon!)
Minimum market cap listing increased from £700k to £30m. So Prep (the smallest of the spinoffs) will require a £30m valuation.
IF Prep-001 is assessed and confirmed by PHE to be effective against COVID-19 then the valuation could be very juicy indeed. Exciting times ahead.
Anyway the new rules below:
Increasing the minimum market capitalisation (MMC) threshold for both the premium and standard listing segments for shares in ordinary commercial companies from £700,000 to £30 million. Raising the MMC will give investors greater trust and clarity about the types of company with shares admitted to different markets.
https://www.fca.org.uk/news/press-releases/fca-confirms-new-listing-rules-boost-growth-and-innovation
Just posted this on Twitter so you can see the picture. Something is happening in the background... 500k on the bid via DAVY and pushing us up and other MMs have decent size too. Never seen that before and usually see them with around 110k max. Basically means theres some serious buying demand right now. AKA don't sell your stock when you see the book like this!
https://twitter.com/downunderfutbol/status/1466380383524638730
100 day mission report is out, a brief mention of human challenge trials in their recommendations section:
20. Stringent Regulatory Authorities and the WHO exchange experience and best- practice on regulatory evaluation of other types of studies (e.g. human challenge trials, immunogenicity studies) during pandemics to support the development of appropriate protocols and guidelines.
Also something else - Imutex updated their website again yesterday to several key pages. A lot of activity happening the last week on it in particular. A sign things are moving forward? PR machine ramping up via ConservBioscience and articles are being published. Always a good sign ahead of an investor roadshow for a IPO listing.
"I now realise that patience is the number one prerequisite for successful investing - buying into a growing business & staying with it. And better still, adding more if my belief in the business holds firm."
This is from John Lee, one of the UK’s most successful private investors. Beginning with an investment pot of £125,000 in the early 1980s, by 2003 he had turned this into a thriving portfolio of over £1 million, and it has significantly increased in value since then. Using efficient investment methods, as well as pursuing a winning ‘buy and hold’ strategy, he was the UK’s first ISA millionaire.
https://www.ft.com/content/98b5ec38-90b8-4b97-8384-27da2404dea0?segmentId=6faa8072-922c-4fbf-5b33-45a1342b0cc3
Now ask yourself why did you invest in Orph, what has changed since then? Obviously the share price, but has the fundamentals changed to justify selling? IMO the fundamentals are better at 18p than they were back at 6p by a distance. The share price doesnt reflect the company, so sometimes its best just to let the company get on with what they do best and in the end true value will be realised.
I'm willing to give Cathal until the end of this year before I make a judgement on his recent promises that loyal shareholders will be rewarded in spades, and the share price will be much higher by the new year.
Im in other shares that have been screwed over by the Gov indecisions and delays, so many things are out of his control.
Last Monday Sir Patrick Vallance said the 100 day mission report would be out next week (so this week), I think we will be involved in that. Also the covid study that Dr Chiu said would be out in a few weeks is now 2 months in since he said that, and Bruno Speder said they were frustrated with delays but with so many different parties involved its taking longer than they expected.
Go over the reason you invested and detach yourself from the share price, and ask yourself, would you invest today?
Lots of large buys today - does someone know something, or is it just crazy value down at these levels? Time will tell!
Proof that wearables can be crucial in early detection for covid. DIM will be very valuable. Holding onto all my golden Orph tickets!
https://twitter.com/EricTopol/status/1465366588245221376
Just be respectful today towards ODX holders, many will be underwater and could be yet another bloodbath, so really feel for those who have put more than they can afford in. Their results RNS are quite shocking, too much reliance on the UK Gov who have screwed us all over, yet to decide a test for them despite meant to be rolling from April (looking like they never will now). Cash burn is concerning etc.
So much for the UK Gov supporting UK diagnostics.
That was a year ago Losta, but regardless it shows a glimpse into what they had at the time and one would expect them to have ironed any problems out. Remember they can currently sell for Pro use (non exclusive) and have the microbiology framework already in place so NHS etc, so no reason why they couldn't be rolling smaller amounts off the lines already whilst waiting for HUA.
Another article from back then too about the 50m a month capacity
https://www.thebusinessdesk.com/northwest/news/2070781-covid-19-testing-firm-invests-20m-to-ramp-up-kit-production
"Investing in a share is a FINANCIAL commitment but posting about it is an EMOTIONAL commitment. The more time a person spends posting, the more you're sucked into that emotional commitment. It's the emotional commitment that gets in the way of logical decision-making and causes all the trouble on discussion boards."
Wyndrum, they say that capacity in the video at the bottom of the page so can check it out, also you see the video of the actual production line.
Personally I think things will have changed since last year to the downside given that I cant see the rapid saliva protein test being in such demand they could have maintained the supply chain to that extent, and theres always going to be a bottleneck on things like the buffers etc with other tests competing on things like price.
There are a lot of rumours in the past month that capacity would be 20m for the avct test and scalable quickly, but until its confirmed who really knows?
All we really know, is HUA is key to unlocking everything.
Medusa changed their SIC code back in May to a manufacturer:
Nature of business (SIC)
32500 - Manufacture of medical and dental instruments and supplies
https://find-and-update.company-information.service.gov.uk/company/12568206
Also as I said before watch the video from a year ago and listen to them say "we're up to a supply chain of 100m a month.. can scale this to significant volumes”. Now given that volume and that it was last year, everything will be ironed out by now and ready to roll.
https://alderleyanalytical.com/good-luck-medusa-19/
Many questions remain.
Will GAD & Abingdon manufacture AffiDx for pro use and then Medusa19 for Meduflow for home use? What is Medusas additional capacity? We heard Al say before in previous presentations about additional capacity but was vague on it. Until HUA is given then its very clear all under an NDA still. Hopefully not long until things are revealed.
Its a spreadbet, so technically a buy (Also 100% can't be a sell as wasnt possible to sell above 19.8 all day, so no chance you'd get 574k through at 20.) Some real nice buying all today though, hopefully continues tomorrow.
Sir Patrick Vallance @uksciencechief
It was great to meet my @G7 counterparts today alongside guests @WHO @CEPI @Deepmind@gatesfoundation to discuss the ambitious 100 Days Mission - which is to make diagnostics, therapeutics and vaccines available within 100 days. Our implementation report is out next week Memo
https://twitter.com/uksciencechief/status/1462821698026287108
Wonder if theres anyone who could speed up that process via human challenge studies? ;)
Also worth noting that there was some really nice size buying today, particuarly some of note into the close with the RSP on the bid getting very strong. No idea what caused the buying, but positive regardless.
MrA - Stats posted today by Medica of the attendance to prove "how busy it was"
https://mobile.twitter.com/MEDICATradeFair/status/1461658033042374664
Pics of opposite hall 16, j16 where Medusa are which was the UK international trade stand (not mine)
https://mobile.twitter.com/downunderfutbol/status/1461352697945198600
Timster - believe what you want, but I expect you to admit you are wrong when it's all revealed. Good find regarding where they copied the image from, but that doesn't make a brochure fake. Enjoy your night anyway, better things to be doing than being on LSE, let alone doing a photoshop!